Health Care & Life Sciences » Pharmaceuticals | Mitsubishi Tanabe Pharma Corp.

Mitsubishi Tanabe Pharma Corp. | Mutual Funds

Mutual Funds that own Mitsubishi Tanabe Pharma Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
4,203,899
0.75%
-113,018
0.01%
12/31/2017
Nomura Asset TOPIX ETF Fund (1306)
3,853,200
0.69%
61,000
0.09%
07/31/2018
Vanguard Total International Stock Index Fund
3,138,645
0.56%
31,400
0.02%
07/31/2018
iShares MSCI EAFE Minimum Volatility ETF
2,686,200
0.48%
0
0.51%
09/06/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
2,452,398
0.44%
-1,364,463
0.01%
03/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
1,891,100
0.34%
43,500
0.09%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
1,735,400
0.31%
0
0.09%
08/20/2018
WisdomTree Japan Hedged Equity Fund
1,515,100
0.27%
0
0.48%
09/06/2018
Vanguard Developed Markets Index Fund
1,248,763
0.22%
-1,200
0.02%
07/31/2018
Canada Pension Plan
1,212,000
0.22%
-386,000
0.01%
03/31/2018

About Mitsubishi Tanabe Pharma

View Profile
Address
3-2-10 Dosho-machi
Osaka Osaka 541
Japan
Employees -
Website http://www.mt-pharma.co.jp
Updated 07/08/2019
Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company operates through Pharmaceuticals segment.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.